Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lysozyme is a hydrolytic enzyme and a key component of the innate immune system, found in various animal and plant sources. It functions as an antimicrobial agent by degrading bacterial cell walls, and it also plays a role in modulating immune responses. Its structure and mechanism have been extensively studied, making it a model enzyme in biochemistry. Lysozyme has applications in food preservation, pharmaceuticals, and potentially in cancer therapy due to its immunomodulatory properties.
Lysozyme hydrolyzes the β-(1,4)-glycosidic bond between N-acetylmuramic acid (NAM) and N-acetylglucosamine (NAG) in peptidoglycan, leading to bacterial cell wall lysis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lysozyme.